Patents by Inventor Pierre Raboisson

Pierre Raboisson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel substituted pyrazolo[1,5A]-1,3,5-Triazine derivatives and their analogues, pharmaceutical compositions containing same, use thereof as medicine and methods for preparing same
    Publication number: 20090105261
    Abstract: The invention relates to novel derivatives capable of increasing the synthesis and/or the release of neurotrophic factors, and therefore able to be used as a human or veterinary medicinal product. The invention also relates to methods for preparing the derivatives and also to the intermediates required for their synthesis.
    Type: Application
    Filed: December 1, 2008
    Publication date: April 23, 2009
    Applicant: GREENPHARMA
    Inventors: Philippe Bernard, Pierre Raboisson, Benoit Joseph
  • Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof
    Patent number: 7250410
    Abstract: The invention concerns novel benzodiazepine derivatives and their uses in the field of therapeutics particularly for treating pathologies involving the activity of a cyclic nucleotide phosphodiesterase. It also concerns methods for preparing them and novel synthesis intermediates.
    Type: Grant
    Filed: June 7, 2002
    Date of Patent: July 31, 2007
    Assignee: Via Pharmaceuticals, Inc.
    Inventors: Jean-Jacques Bourguignon, Yan Lagouge, Claire Lugnier, Eveline Klotz, Jean-Paul Macher, Pierre Raboisson, Dominique Schultz
  • Substituted 1,4-diazepines and uses thereof
    Publication number: 20060235007
    Abstract: The present invention is directed to novel 1,4-diazepines, pharmaceutical compositions thereof and the use thereof as inhibitors of HDM2-p53 interactions.
    Type: Application
    Filed: June 14, 2006
    Publication date: October 19, 2006
    Inventors: Tianbao Lu, Karen Milkiewicz, Pierre Raboisson, Maxwell Cummings, Raul Calvo, Daniel Parks, Louis LaFrance, Juan Marugan Sanchez, Joan Gushue, Kristi Leonard
  • Substituted 1,4-diazepines and uses thereof
    Patent number: 7115598
    Abstract: The present invention is directed to novel 1,4-diazepines, pharmaceutical compositions thereof, and the use thereof as inhibitors of HDM2-p53 interactions.
    Type: Grant
    Filed: April 21, 2004
    Date of Patent: October 3, 2006
    Assignee: Ortho-McNeil Pharmaceutical, Inc.
    Inventors: Tianbao Lu, Karen L. Milkiewicz, Pierre Raboisson, Maxwell David Cummings, Raul R. Calvo, Daniel J. Parks, Louis V. Lafrance, III, Juan Jose Marugan Sanchez, Joan Gushue, Kristi Leonard
  • Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses
    Publication number: 20060128695
    Abstract: The invention concerns the use of PDE2 inhibitors for treating disorders of the central and peripheral nervous system, a method for therapeutic treatment by administering to an animal said inhibitors. More specifically, the invention concerns novel benzodiazepinone derivatives and their uses in therapeutics more particularly for treating pathologies involving activity of a cyclic nucleotide phosphodiesterase type 2. The invention also concerns methods for preparing same and novel synthesis intermediates.
    Type: Application
    Filed: October 30, 2003
    Publication date: June 15, 2006
    Applicants: NEURO3D, UNIVERSITE LOUIS PASTEUR
    Inventors: Jean-Jacques Bourguignon, Claire Lugnier, Mustapha Abarghaz, Yan Lagouge, Patrick Wagner, Cesare Mondadori, Jean-Paul Macher, Dominique Schultz, Pierre Raboisson
  • Substituted 1,4-diazepines and uses thereof
    Publication number: 20040220179
    Abstract: The present invention is directed to novel 1,4-diazepines, pharmaceutical compositions thereof, and the use thereof as inhibitors of HDM2-p53 interactions.
    Type: Application
    Filed: April 21, 2004
    Publication date: November 4, 2004
    Inventors: Tianbao Lu, Karen L. Milkiewicz, Pierre Raboisson, Maxwell David Cummings, Raul R. Calvo, Daniel J. Parks, Louis V. Lafrance, Juan Jose Marugan Sanchez, Joan Gushue, Kristi Leonard
  • Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof
    Publication number: 20040152888
    Abstract: The invention concerns novel benzodiazepine derivatives and their uses in the field of therapeutics particularly for treating pathologies involving the activity of a cyclic nucleotide phosphodiesterase. It also concerns methods for preparing them and novel synthesis intermediates.
    Type: Application
    Filed: November 26, 2003
    Publication date: August 5, 2004
    Inventors: Jean-Jacques Bourguignon, Yan Lagouge, Claire Lugnier, Eveline Klotz, Jean-Paul Macher, Pierre Raboisson, Dominique Schultz